Marksans Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
652.98
605.57
576.54
590.93
550.23
Other Income Qtr Cr11.0614.9516.534.8019.00
Operating Revenues Qtr641.92590.62560.01586.13531.24

*All values are in Cr.

Operating Expenses Qtr
506.24
462.18
450.37
453.10
417.29
Operating Profit Qtr
135.68
128.44
109.64
133.02
113.95
EBIDT Qtr Cr
146.74
143.38
126.17
137.82
132.94
Depreciation Qtr
19.51
20.44
21.06
22.00
17.55
Net Profit Qtr
96.72
88.75
78.29
83.24
83.52
Basic EPS Qtr
2.13
1.96
1.73
1.84
1.84
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -